4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-23-006526
Chief Executive Officer sold 32,750 shares at $8.94 ($292,785)
- Chief Executive Officer acquired 667,407 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Greenleaf Peter Chief Executive Officer | 2023-03-02 | Grant or award | +667,407 | 1,015,718 | D | ||
| Greenleaf Peter Chief Executive Officer | 2023-03-02 | Sale | −32,750 | $8.94 | $292,785 | 982,968 | D |
| Open-market sales · 32,750 sh · avg $8.94 · $292,785 | |||||||
Loading xslF345X03/wf-form4_167813805672591.xml…